About Us

Rapid development of antimicrobial peptides (AMPs) as alternatives to conventional small molecule antibiotics. Targeting urgent global risks including antimicrobial resistance.

As a Research and Development Biotechnology Company we are generating solutions against antimicrobial resistance, safeguarding human health and securing the food chain for a growing world population. 

Our current target is to translate AMPs for use in veterinary applications – specifically in poultry meat and egg production – as well as novel human therapeutics.